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Abstract: Prediction of the outcome and severity of acute upper gastrointestinal bleeding (UGIB) has significant impor-
tance in patient care, disposition, and determining the need for emergent endoscopy. Recent international rec-
ommendations endorse using scoring systems for management of non-variceal UGIB patients. To date, differ-
ent scoring systems have been developed for predicting the risk of 30-day mortality and re-bleeding. We have
discussed the screening performance characteristics of Baylor bleeding score, the Rockall risk scoring score,
Cedars-Sinai Medical Center predictive index, Glasgow Blatchford score, T-score, and AIMS65 systems, in the
present review. Based on the results of this survey, there are only 3 clinical decision rules that can predict the
outcome of UGIB patients, independent from endoscopy. Among these, only Glasgow Blatchford score was
highly sensitive for predicting the risk of 30-day mortality and re-bleeding, simultaneously.
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1. Introduction
P
rediction of the outcome and severity of upper gas-
trointestinal bleeding (UGIB), with 10% mortality rate,
has significant importance in patientcare, disposition,
and determining the need for emergent endoscopy (1, 2).
Some clinical criteria such as hemodynamic and mental sta-
tus, volume of blood lost, and coagulopathy profile were used
in determining the patient’s outcome (3). In addition, early
upper gastrointestinal endoscopy, within the first 24 hours
of emergency department (ED) arrival, is recommended for
treatment as well as outcome prediction of these patients
(1). Clots adhering to the ulcer, visible bleeding, and visible
vessel in the ulcer are associated withhigh probability of re-
bleeding. On the other hand, brown or black pigments on the
ulcer andclean based ulcerare associated with high probabil-
ity of re-bleeding (3, 4). Endoscopic triage of these patients
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could reduce duration of hospital stay and costs, but due to
lack of endoscopy devices and absence of interventionists,
it is not obtainable in the majority of EDs (5). To date, dif-
ferent clinical scoring systems have been developed to pre-
dict the outcome and guide the management and disposition
of these patients (3, 6). Recent international recommenda-
tions regarding management of non-variceal UGIB patients
endorse using these systems for risk stratification in the first
visit. Table 1 and 2 show the sensitivity, specificity, PPV (Pos-
itive Predictive Value), NPV (Negative Predictive Value) of 6
scoring system in the prediction of 30 days mortality and re-
bleeding (7), (8), (9). Hereby, 6 of these scoring systems and
their screening performance characteristics will be discussed
comprehensively.
2. Endoscopy dependent scoring sys-
tems
2.1. Baylor bleeding score (BBS)
This scoring system was introduced by Saeed ZA et al, in
1993. They designed it for predicting the risk of re-bleeding
in patients with UGIB (table 3). This scoring system contains
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Table 1: Screening performance characteristics of scoring systems in predicting re-bleeding risk in upper gastrointestinal bleeding
Scores Sensitivity Specificity PPV NPV
GBS 1.00 0.12 0.07 1.00
BBS 1.00 0.26 0.10 1.00
CSMCPI 0.88 0.32 0.10 0.97
RS 1.00 0.28 0.10 0.99
AIMS65 0.35 0.82 0.89 0.23
PPV: Positive predictive value, NPV: Negative predictive value,
GBS: Glasgow Blatchford score, BBS: Baylor bleeding score,
CSMCPI: Cedars-Sinai Medical Center predictive index, RS: Rockall risk scoring score.
Table 2: Screening performance characteristics of scoring systems in predicting 30-day mortality in upper gastrointestinal bleeding
Scores Sensitivity Specificity PPV NPV
GBS 0.97 0.13 0.14 0.97
BBS 0.97 0.27 0.14 0.98
CSMCPI 0.97 0.29 0.15 0.99
RS 0.96 0.27 0.14 0.98
T score 0.71 0.80 0.78 0.73
AIMS65 0.35 0.82 0.89 0.23
PPV: Positive predictive value, NPV: Negative predictive value,
GBS: Glasgow Blatchford score, BBS: Baylor bleeding score,
CSMCPI: Cedars-Sinai Medical Center predictive index, RS: Rockall risk scoring score.
three parts, namely pre-endoscopy, during endoscopy, and
post-endoscopy. The score of ≥ 6 in the pre-endoscopy part
and ≥ 11 in the total score have 100% sensitivity for predict-
ing the risk of re-bleeding (10, 11). In another research in
1995, the same authors indicated that the score of ≤ 5 be-
fore endoscopy and ≤ 10 after endoscopy are associated with
low re-bleeding risk. They finally revealed that BBS deter-
mines high-risk patients prone to re-bleeding after successful
hemostatic endoscopy with high accuracy (12).
2.2. Rockall risk scoring score (RS)
Rockall et al. introduced RS system in 1997. This score
consists of two parts: pre-endoscopy, also known as clinical
Rockall score, and post-endoscopy, which is called the Rock-
all risk score (table 4). They figured out that as the score in-
creases, the chance of mortality or re-bleeding increases (2,
13). Different studies indicated that this system is practical,
accurate, and a quick tool in prediction of re-bleeding and
mortality risk (14-16). Evaluating the system in patients with
non-variceal UGIB, Rahman MW showed that the score of ≤
3 predicts low risk, while ≥ 8 is a predictor of high mortality
risk. They also revealed the good performance index of RS
system in UGIB patients triage(17).
2.3. Cedars-Sinai Medical Center Predictive In-
dex (CSMCPI)
This scoring system has been introduced according to the
suggestions by American Society of Endoscopy of the Diges-
tive System in 1981 (18). It consists of four sections (table 5).
The first one was related to endoscopic findings, the second
dealt with the time interval between symptom initiation and
hospitalization, the third section was related to the hemody-
namic status of the patient, and finally the fourth section was
related to the number of comorbidities. The total score of
the patient was the sum of scores obtained from these four
sections (18, 19). Patients with a score < 3 can be discharged
from ED and others need hospitalization. These patients are
re-evaluated after 24-72 hours based on endoscopy results. A
validation study in 1997 showed that application of this scor-
ing system with great accuracy, can lead to decreased dura-
tion of hospital stay (20).
3. Clinical scoring systems (independent
from endoscopy)
3.1. Glasgow Blatchford score (GBS)
Blatchford et al. studied the mortality rate of 1882 UGIB pa-
tients previously under gone endoscopy to introduce a new
scoring system for predicting UGIB patient’s need for ther-
apeutic interventions and blood transfusion as well as mor-
tality risk, re-bleeding, and dropped hemoglobin levels after
hospitalization (table 6) (21). A study evaluating the validity
of this score in 2000 showed that patients with a score of zero
belong to the low-risk group, and can be discharged from ED
(22). Stanley et al. compared GBS and RS in a multicenter
study and concluded that none of the patients categorized
as low risk in the GBS scoring system, needed intervention
during hospitalization and no mortality was observed in this
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Table 3: Baylor Bleeding Score and interpretation
Score
Pre-endoscopy Score (range: 0-15) Endoscopy Score(range: 0 - 9)
Age(years) No. of illnesses Severity of illnesses Site of bleeding Stigmata of bleeding
0 < 30 0
1 30 - 49 1 or 2 Clot
2 50 - 59
3 60 - 69 Visible vessel
4 3 or 4 Chronic Posterior bulb
5 ≥ 70 ≥5 Acute Active bleeding
Total score is the sum of scores obtained for each item, which ranges from 0 to 24. Score ≥ 6 in pre-endoscopic phase and total score ≥ 11
indicate high-risk patients for re-bleeding. Example: A 34-year-old patient (score: 1) with chronic (score: 4) hepatic failure (score: 1) and
adhering clot (score: 1) on ulcer in endoscopy has a score of 7 (1 + 4 + 1+ 1).
Table 4: Rockall risk scoring score and interpretation
Variable
Score
0 1 2 3
Age (year) < 60 60–79 ≥ 80
Shock stage
SBP (mmHg) ≥ 100 ≥ 100 < 100
PR (1/minute) < 100 ≥ 100 -
Comorbidity No major comorbidity Cardiac failure, is-
chemic heart disease,
any major comorbidity
Renal failure, liver fail-
ure, disseminated ma-
lignancy
Diagnosis Mallory-Weiss tear, no
lesion identified and no
SRH
All other diagnosis Malignancy of upper GI
tract
Major SRH None or dark spot only Blood in upper GI tract,
adherent clot, visible or
spurting vessel
SPB: Systolic blood pressure, PR: Pulse rate,
GI: Gastrointestinal, SRH: Signs of recent hemorrhage.
Range of score is 0-11. Score of ≤ 3 predicts low mortality risk, while ≥ 8 is a predictor of high mortality risk.
Table 5: Cedars-Sinai Medical Center predictive index and interpretation
Score Endoscopic findings Time∗ Hemodynamics Comorbidities
0 PUD (no SRH), Mallory-
Weiss tear (NB), Erosive
disease (no SRH), Normal
finding
> 48 Stable ≤ 1
1 PUD (spot/clot), Erosive
disease (SRH), Angiodys-
plasia
< 48 Intermediate 2
2 PUD (VVNB/SRH) In hospital Unstable 3
3 ≥ 4
4 Persistent UGIH, Varices,
UGI cancer
∗ Time means the interval between the initiation of bleeding and arrival to emergency department (hour),
NB: Non-bleeding, PUD: Peptic ulcer disease,
SRH: Signs of recent hemorrhage, UGI: Upper gastrointestinal,
UGIH: Upper gastrointestinal hemorrhage, VVNB: Visible vessel, non-bleeding.
Score range is 0 to 11. Patients with a score < 3 can be discharged from ED and others need hospitalization. The criteria of hemodynamic
classification was not clearly defined.
group. Eventually, the authors concluded that application of
GBS can contribute to reducing hospitalization rate and costs
in low-risk patients (23).
3.2. Modified Glasgow Blatchford score (mGBS)
D.W. Cheng et al introduced a modified type of GBS system
(mGBS). In this system, three variables related to syncope,
melena, and comorbidities were omitted from the GBS, and
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Table 6: Glasgow Blatchford score
Admission risk markers Score
Blood urea nitrogen level (mg /dl )
≥ 18.2to < 22.4 2
≥ 22.4to < 28 3
≥ 28to < 70 4
≥ 70 6
Hemoglobin level for men (g /dl )
≥ 12to < 13 1
≥ 10to < 12 3
< 10 6
Hemoglobin level for women (g /dl )
≥ 10to < 12 1
<10 6
Systolic blood pressure (mmHg)
≥ 100to < 109 1
≥ 90to < 99 2
< 90 3
Other markers
Pulse rate ≥ 100 beats/min 1
Presentation with melena 1
Presentation with syncope 2
Hepatic disease∗ 2
Heart failure] 2
∗ Known history, or clinical and laboratory findings of
chronic or acute hepatic disease.
] Known history, or clinical and echocardiographic findings
of heart failure.
- Range of score is 0-29. Score > 0 is high-risk group.
the new scoring system was introduced based on the status of
clinical and laboratory findings and patient symptoms. They
concluded that the mGBS score could predict the outcome of
patients with high accuracy. It is also more convenient to use
compared to GBS (2).
3.3. T-score system
T-score system was designed based on the clinical status of
UGIB patients before performing endoscopy (table 7). Pa-
tient’s general appearance, number of comorbid diseases,
pulse rate, systolic blood pressure, and hemoglobin level are
among T score variables. A score <6 indicates high-risk sta-
tus (T1), a score between 7 and 9 shows moderate-risk status
(T2), and a score of ≥ 10 reveals low-risk status (T3). Good
clinical conditions include a patient without weakness or or-
thostatic hypotension who have ≤ 1comorbidity. Validation
studies concluded that this score could determine the need
of UGIB patients for early endoscopy with an accuracy equal
to GBS (9, 24).
3.4. AIMS65 system
Recently, a simple score was introduced by Saltzman JR et al.
for evaluating the prognosis of UGIB patients. It includes five
variables: age over 65, systolic blood pressure lower than 90
mmHg, altered level of consciousness, international normal-
ized ratio (INR) higher than 1.5, and serum albumin lower
than 3 g/dL. The patient would receive one score for pres-
ence of each variable. Eventually, mortality rate was esti-
mated to be 0.3% for score 0, 1.2% for score 1, 5.3% for score
2, 10.3% for score 3,16.5% for score 4, and 24.5% for score
5. Scores of 0-1 and 2-5 are related to low-risk and high-risk
patients, respectively. Saltzman JR et al.concluded that this
score has high accuracy in prediction of in-hospital mortal-
ity, length of hospital stay, and reduction of the hospitaliza-
tion cost in patients with UGIB (5). Hyett BH et al. compared
AIMS65 and GBS and concluded that AIMS65 is more accu-
rate in prediction of mortality in comparison with GBS, while
GBS is more accurate in estimation of need for blood trans-
fusion. Both scores were similar in prediction of other out-
comes (25). Yaka E et al. also compared AIMS65 and GBS,
and concluded that GBS has a lower sensitivity in predict-
ing the need for emergent intervention in comparison with
AIMS65 (5).
4. Discussion
In this narrative review, we evaluated 6 different scoring sys-
tems to predict the outcome of patients with acute UGIB.
Each of these systems used different variables in predicting
the outcome of acute UGIB patients. Based on the findings
of this review, only AIMS65, GBS, and T score were designed
to determine the outcome of UGIB patients without need-
ing emergency endoscopy. Furthermore, only AIMS65 score
determines the outcome of patients disregarding comorbidi-
ties and only based on the patient’s current clinical status.
Some researchers want to predict the patient’s outcome with-
out considering the comorbidities or even endoscopy results,
so they have modified some scoring system such as GBS or
Clinical Rockall Score. A weak point of CSMCPI score was
that definition of hemodynamic status was vague in this sys-
tem (8). Table 1 and 2 summarize the screening performance
characteristics of these scoring systems in the risk predic-
tion of re-bleeding and 30-day mortality. In the case of pre-
dicted probability of re-bleeding, RS, BBS, and CSMCPI have
similar values and these systems do not have any significant
differences in prediction of re-bleeding, but AIMS65 score
has a higher specificity and positive predictive value(82%,
and 89% respectively), in this regard. These characteristics
represent the great value of this system compared to oth-
ers. In addition, AIMS65 and T score have the same value
in predicting 30-day mortality. Another difference of AIMS65
with other systems is that, unlike the others, it only assesses
the current clinical status of the patient, regardless of un-
derlying diseases. Despite the presence of all these scoring
systems, none is routinely used in emergency departments.
This might be due to various reasons such as lack of vali-
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General conditions Poor Intermediate Good
Pulse (beats/minute) > 110 90–110 < 90
Systolic blood pressure (mmHg) < 90 90 – 110 > 110
Hemoglobin levels (g/dl) ≤ 8 9– 10 > 10
General condition was defined based on the patient’s number of comorbidities.
Poor condition was associated with ≤3 comorbidities or impending to shock.
Good condition means a patient is without weakness or orthostatic hypotension and has ≤ 1 comorbidity. Intermediate condition
includes patients with conditions between the mentioned two groups.
A score < 6 indicates high-risk (T1), a score between 7 and 9 shows moderate-risk (T2), and a score of ≥ 10 reveals low-risk patients (T3)
for detection of major findings in endoscopy.
dation studies, not being user-friendly, and not believing in
evidence-based medicine. It seems that we need further val-
idation studies prior to implementing these clinical decision
rules in our routine practice.
5. Conclusion
Based on the results of this survey, there are only 3 clinical
decision rules that can predict the outcome of UGIB patients,
independent from endoscopy. Among these, only Glasgow
Blatchford score was highly sensitive for predicting the risk
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